Calliditas Therapeutics AB
Calliditas Therapeutics AB is grouped at the issuer level across 1 linked ticker lifecycle, combining public listing, delisting, source, and shareholder outcome records from the archive.
Lifecycle Map
Issuer enters the archive
May 14, 2020Calliditas Therapeutics AB is represented as an issuer-level entity with 1 linked public-market ticker lifecycle.
Delisting event
Sep 13, 2024Removed from listing - SEC Form 25 filed.
SourceCALT stopped trading
Sep 13, 2024CALT is linked to Calliditas Therapeutics AB and ended with final status "delisted".
Source
Entity Graph
Calliditas Therapeutics ABissuedCALT
CALTlisted onNASDAQ
CALTresulted inunknown
Source-Backed Claims
- Calliditas Therapeutics AB filed a Form 25 to notify of removal from listing and/or registration under Section 12(b) of the Securities Exchange Act of 1934.Form 25
- The issuer's Commission File Number is 001-39308, according to the Form 25 filed.Form 25
- Calliditas Therapeutics AB's principal executive office is located at Kungsbron 1, C8, Stockholm, Sweden, SE-111 22.Form 25
- The American Depositary Shares were specified as the class of securities involved in the filing.Form 25
- Nasdaq Stock Market LLC certified it has reasonable grounds to believe it meets all the requirements for filing the Form 25.Form 25
- Tara Petta, Director, signed the Form 25 on behalf of Nasdaq Stock Market LLC.Form 25
Associated Tickers
Public-market security lifecycles tied to this issuer record.